大健康&CB insights：2019年第二季度健康产业报告（英文版）(70页).pdf

《大健康&CB insights：2019年第二季度健康产业报告（英文版）(70页).pdf》由会员分享，可在线阅读，更多相关《大健康&CB insights：2019年第二季度健康产业报告（英文版）(70页).pdf（70页珍藏版）》请在三个皮匠报告上搜索。

1、1 Global Healthcare Report Q2 2019 W HAT IS CB INSIGHTS? CB Insights is a tech market intelligence platform that analyzes millions of data points on venture capital, startups,patents, partnerships, and news mentions to help you see tomorrows opportunities, today. CLICK HERE TO LEARNMORE 3 T R US TED

2、 B Y T H E W O R L DS L EAD ING C O M P ANIES “We use CB Insights to find emerging trends and interesting companies that might signal a shift in technology or require us to reallocate resources.” Beti Cung, Corporate Strategy, Microsoft October 2-3, 2019 New York, NY 5 Contents 8Q219 Investment Tren

3、ds Quarterly Deals & Dollars Regional Trends Q219 Top VC-Backed Digital Health Deals Digital Health Unicorns 66 28Q219 Healthcare Industry Highlights Clinical Trials Womens Health Cannabis AI Mental Health & Wellness Genomics Digital Therapeutics Appendix: Most Active Digital Health Investors Q219 M

4、ethodology 6 Hemp/CBD startups take a record 25% of cannabis funding: In Q219, 27 (25%) of the 107 cannabis deals were for startups with a hemp and/or CBD business component. That compares to only 11 (15%) of the 73 deals in Q218. AI in healthcare startups and mental health & wellness startups reach

5、 funding highs in Q219: Healthcare AI companies raised $864M in the second quarter, led by a $200M round to Tempus in May. Mental health & wellness companies raised $321M across 26 deals, with large rounds going to Quartet and Talkspace. The application of emerging technologies in genomics is pickin

6、g up: New platforms such as telegenomics and blockchain-enabled networks are becoming more prevalent. Digital therapeutics continue to provide new avenues of treatment for chronic disease management: This quarter has seen deals going to startups pursuing more specific health issues such as joint pai